BNGO News and Press, Bionano Genomics Inc. From 05/05/22

Bionano Genomics (NASDAQ:BNGO), a provider of optical genome mapping (OGM) solutions, is trading lower in the post-market Thursday despite reporting better than expected revenue for 1Q 2022 as the company’s net loss for the period climbed after a decline in gross margin. The total...

Bionano Genomics press release (NASDAQ:BNGO): Q1 Net loss of $29.52M. Revenue of $5.7M (+79.8% Y/Y) beats by $0.02M. Expanded the installed base of Saphyr systems to 176 as of the end of Q1 2022, up from 164 as of the end of Q4 2021 and an increase of 64% over Q1 2021. CEO comment:  ...

- 80% year-over-year revenue growth in Q1 2022 - Achieved all Q1 2022 ELEVATE! milestones - Strong balance sheet with $216.5 million in cash, cash equivalents, and available-for-sale securities at the end of Q1 2022 - Conference call today, May 5th, 2022 at 4:30 PM...

SAN DIEGO, April 29, 2022 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO), pioneer of optical genome mapping (OGM) solutions on the Saphyr ® system and provider of N x Clinical™ software, the leading solution for visualization, interpretation and reporting of g...

SAN DIEGO, April 28, 2022 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (BNGO) today announced that it will host a conference call and live webcast on Thursday, May 5th, 2022 at 4:30 p.m. Eastern Time to report financial results for the first quarter 2022 and to highlight recent corporate...

Bionano Genomics (NASDAQ:BNGO) said the the U.S. Patent and Trademark Office issued two new US Patents, No. 11,291,999 and No. 11,292,713 on April 5. The company said the ‘999 patent named, 'Photocleavage method and apparatus to clean fluidic devices,' claims a new apparatus ...

SAN DIEGO, April 14, 2022 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO), pioneer of optical genome mapping (OGM) solutions on the Saphyr ® system and provider of N x Clinical™ software, the leading solution for visualization, interpretation and reporting of g...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Bionano Genomics (NASDAQ: BNGO ) is a life sciences company that provides genome analysis software solutions. It recently announced two important studies about the progress of its genome analysis space. This bodes wel...

SAN DIEGO, April 07, 2022 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. ( BNGO ), pioneer of optical genome mapping (OGM) solutions on the Saphyr ® system and provider of N x Clinical™ software, the leading solution for visualization, interpretation and reporting of gen...

Life sciences company, Bionano Genomics (BNGO -8.3%), is trading lower for the second consecutive session on Wednesday after BTIG moved to slash its price target following a revision to the valuation model. However, arguing that the maker of the Saphyr System for optical genome mapping (OGM) ...